InsideArbitrage Potential Deal Alert: Biogen (BIIB) Submits Bid to Acquire Sage Therapeutics (SAGE) for $7.22 Per Share
Sage Therapeutics (SAGE) announced that Biogen (BIIB) has submitted an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage not already owned
Read More